These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 26104049)

  • 21. Impact of chronic obstructive pulmonary disease on exercise ventilatory efficiency in heart failure.
    Apostolo A; Laveneziana P; Palange P; Agalbato C; Molle R; Popovic D; Bussotti M; Internullo M; Sciomer S; Bonini M; Alencar MC; Godinas L; Arbex F; Garcia G; Neder JA; Agostoni P
    Int J Cardiol; 2015; 189():134-40. PubMed ID: 25889444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patient-Specific Tailored Intervention Improves INR Time in Therapeutic Range and INR Variability in Heart Failure Patients.
    Gotsman I; Ezra O; Hirsh Raccah B; Admon D; Lotan C; Dekeyser Ganz F
    Am J Med; 2017 Aug; 130(8):982-989. PubMed ID: 28344144
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of chronic kidney disease on warfarin management in a pharmacist-managed anticoagulation clinic.
    Kleinow ME; Garwood CL; Clemente JL; Whittaker P
    J Manag Care Pharm; 2011 Sep; 17(7):523-30. PubMed ID: 21870893
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes of heart rate variability predicting patients with acute exacerbation of chronic obstructive pulmonary disease requiring hospitalization after Emergency Department treatment.
    Tseng CY; Chang JC; Chen YC; Huang HH; Lin CS; How CK; Yen DH
    J Chin Med Assoc; 2018 Jan; 81(1):47-52. PubMed ID: 29254670
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical characteristics and outcomes of hospitalized heart failure patients with systolic dysfunction and chronic obstructive pulmonary disease: findings from OPTIMIZE-HF.
    Mentz RJ; Fiuzat M; Wojdyla DM; Chiswell K; Gheorghiade M; Fonarow GC; O'Connor CM
    Eur J Heart Fail; 2012 Apr; 14(4):395-403. PubMed ID: 22302663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acutely decompensated heart failure: characteristics of hospitalized patients and opportunities to improve their care.
    Sarmento PM; Fonseca C; Marques F; Ceia F; Aleixo A
    Rev Port Cardiol; 2006 Jan; 25(1):13-27. PubMed ID: 16623353
    [TBL] [Abstract][Full Text] [Related]  

  • 27. International normalized ratio stabilization in newly initiated warfarin patients with nonvalvular atrial fibrillation.
    Nelson WW; Desai S; Damaraju CV; Lu L; Fields LE; Wildgoose P; Schein JR
    Curr Med Res Opin; 2014 Dec; 30(12):2437-42. PubMed ID: 25170587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. COPD in chronic heart failure: less common than previously thought?
    Minasian AG; van den Elshout FJ; Dekhuijzen PN; Vos PJ; Willems FF; van den Bergh PJ; Heijdra YF
    Heart Lung; 2013; 42(5):365-71. PubMed ID: 23998385
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic obstructive pulmonary disease in patients admitted with heart failure.
    Iversen KK; Kjaergaard J; Akkan D; Kober L; Torp-Pedersen C; Hassager C; Vestbo J; Kjoller E;
    J Intern Med; 2008 Oct; 264(4):361-9. PubMed ID: 18537871
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiovascular function and prognosis of patients with heart failure coexistent with chronic obstructive pulmonary disease.
    Yoshihisa A; Takiguchi M; Shimizu T; Nakamura Y; Yamauchi H; Iwaya S; Owada T; Miyata M; Abe S; Sato T; Suzuki S; Oikawa M; Kobayashi A; Yamaki T; Sugimoto K; Kunii H; Nakazato K; Suzuki H; Saitoh S; Takeishi Y
    J Cardiol; 2014 Oct; 64(4):256-64. PubMed ID: 24674751
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of beta-blocker use and selectivity with outcomes in patients with heart failure and chronic obstructive pulmonary disease (from OPTIMIZE-HF).
    Mentz RJ; Wojdyla D; Fiuzat M; Chiswell K; Fonarow GC; O'Connor CM
    Am J Cardiol; 2013 Feb; 111(4):582-7. PubMed ID: 23200803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Poor correlation of supratherapeutic international normalised ratio and vitamin K-dependent procoagulant factor levels during warfarin therapy.
    Sarode R; Rawal A; Lee R; Shen YM; Frenkel EP
    Br J Haematol; 2006 Mar; 132(5):604-7. PubMed ID: 16445834
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of warfarin-associated coagulopathy with oral vitamin K: a randomised controlled trial.
    Crowther MA; Julian J; McCarty D; Douketis J; Kovacs M; Biagoni L; Schnurr T; McGinnis J; Gent M; Hirsh J; Ginsberg J
    Lancet; 2000 Nov; 356(9241):1551-3. PubMed ID: 11075768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differences in clinical characteristics, management and short-term outcome between acute heart failure patients chronic obstructive pulmonary disease and those without this co-morbidity.
    Parissis JT; Andreoli C; Kadoglou N; Ikonomidis I; Farmakis D; Dimopoulou I; Iliodromitis E; Anastasiou-Nana M; Lainscak M; Ambrosio G; Mebazaa A; Filippatos G; Follath F
    Clin Res Cardiol; 2014 Sep; 103(9):733-41. PubMed ID: 24718849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of heart failure on the classification of COPD severity.
    Güder G; Rutten FH; Brenner S; Angermann CE; Berliner D; Ertl G; Jany B; Lammers JW; Hoes AW; Störk S
    J Card Fail; 2012 Aug; 18(8):637-44. PubMed ID: 22858080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment for Multiple Acute Cardiopulmonary Conditions in Older Adults Hospitalized with Pneumonia, Chronic Obstructive Pulmonary Disease, or Heart Failure.
    Dharmarajan K; Strait KM; Tinetti ME; Lagu T; Lindenauer PK; Lynn J; Krukas MR; Ernst FR; Li SX; Krumholz HM
    J Am Geriatr Soc; 2016 Aug; 64(8):1574-82. PubMed ID: 27448329
    [TBL] [Abstract][Full Text] [Related]  

  • 37. COPD predicts mortality in HF: the Norwegian Heart Failure Registry.
    De Blois J; Simard S; Atar D; Agewall S;
    J Card Fail; 2010 Mar; 16(3):225-9. PubMed ID: 20206897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High intra- and inter-individual variability of plasma vitamin K concentrations in patients with atrial fibrillation under warfarin therapy.
    Kim YE; Woo HI; On YK; Kim JS; Lee SY
    Eur J Clin Nutr; 2015 Jun; 69(6):703-6. PubMed ID: 25828628
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Right Heart Failure as a Risk for Stroke in Patients with Chronic Obstructive Pulmonary Disease: A Case-Control Study.
    Orea-Tejeda A; Bozada-Gutiérrez K; Pineda-Juárez J; González-Islas D; Santellano-Juárez B; Keirns-Davies C; Peláez-Hernández V; Hernández-Zenteno R; Sánchez-Santillán R; Cintora-Martínez C
    J Stroke Cerebrovasc Dis; 2017 Dec; 26(12):2988-2993. PubMed ID: 28844547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Depressive symptoms and quality of life in elderly patients with exacerbation of chronic obstructive pulmonary disease or cardiac heart failure: preliminary data of a randomized controlled trial.
    Aimonino N; Tibaldi V; Barale S; Bardelli B; Pilon S; Marchetto C; Zanocchi M; Molaschi M
    Arch Gerontol Geriatr; 2007; 44 Suppl 1():7-12. PubMed ID: 17317428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.